tiprankstipranks
Genertec Universal Medical Group Company Limited (UMTAF)
OTHER OTC:UMTAF

Genertec Universal Medical Group Company (UMTAF) Financial Statements

8 Followers

Genertec Universal Medical Group Company Financial Overview

Genertec Universal Medical Group Company's market cap is currently ―. The company's EPS TTM is $0.151; its P/E ratio is 3.94; Genertec Universal Medical Group Company is scheduled to report earnings on August 22, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 3.68B¥ 2.34B¥ 3.21B¥ 2.04B¥ 2.83B
Total Assets¥ 77.16B¥ 69.90B¥ 69.89B¥ 61.51B¥ 59.20B
Total Debt¥ 49.49B¥ 47.38B¥ 45.30B¥ 42.84B¥ 39.03B
Net Debt¥ 45.81B¥ 45.04B¥ 42.09B¥ 40.80B¥ 36.20B
Total Liabilities¥ 58.88B¥ 52.28B¥ 52.55B¥ 46.55B¥ 45.20B
Stockholders Equity¥ 14.96B¥ 14.77B¥ 14.55B¥ 12.42B¥ 11.55B
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in CNY

Genertec Universal Medical Group Company Earnings and Revenue History

Genertec Universal Medical Group Company Debt to Assets

Genertec Universal Medical Group Company Cash Flow

Genertec Universal Medical Group Company Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis